Plus Therapeutics, Inc. (PSTV) Discusses Business Update, REYOBIQ Clinical Program Progress, and Recent Financial Offering Transcript
Source: SeekingAlpha
2026-01-22 11:34:43 ET
Plus Therapeutics, Inc. (PSTV) Discusses Business Update, REYOBIQ Clinical Program Progress, and Recent Financial Offering January 22, 2026 9:00 AM EST...
Read the full article on Seeking Alpha
For further details see:
Plus Therapeutics, Inc. (PSTV) Discusses Business Update, REYOBIQ Clinical Program Progress, and Recent Financial Offering Transcript
PLUS THERAPEUTICS Inc.
NASDAQ: PSTV
PSTV Trading
3.35% G/L:
$0.2961 Last:
2,598,812 Volume:
$0.2822 Open:
PSTV Latest News
February 25, 2026 07:30:00 am
Plus Therapeutics Announces New Category III CPT Code for Convection-Enhanced Delivery Used with REYOBIQ(TM)
January 22, 2026 07:45:00 am
Plus Therapeutics Provides Business Update on REYOBIQ(TM) Clinical Program and U.S. CNSide® Commercialization
January 21, 2026 04:15:00 pm
Plus Therapeutics to Provide Business Update and Host Conference Call on Thursday, January 22, 2026 at 9:00 A.M. ET
January 14, 2026 08:00:00 am
Plus Therapeutics Announces Pricing of Upsized $15 Million Public Offering
PSTV Stock Data
$37,787,078
135,702,904
0.32%
20
N/A
Biotechnology & Life Sciences
Healthcare
US
Houston
